NCT05096611

Brief Summary

Maternal depression influences the development of children's behavior problems and vice versa; however most interventions singularly address maternal depression or children's behavior problems rather than both. This project assesses the efficacy of an intervention that treats both mothers and children in an integrated manner. Effects are expected to disrupt the reciprocal relations that perpetuate maternal and child mental health problems over time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 27, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2024

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

April 21, 2026

Completed
Last Updated

April 21, 2026

Status Verified

March 1, 2026

Enrollment Period

2.7 years

First QC Date

October 25, 2021

Results QC Date

January 15, 2026

Last Update Submit

March 30, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Score

    Scores range from 34.5 to 82.3 with higher values indicating more severe symptoms

    Baseline to post-intervention. This is approximately 10 weeks.

  • Change in Early Childhood Screening Assessment (ECSA) Score

    Scores range from 0 to 80 with higher values indicating more severe symptoms

    Baseline to post-intervention. This is approximately 10 weeks.

Study Arms (2)

ABC

ACTIVE COMPARATOR

Attachment and Biobehavioral Catch-up, 10 weekly sessions that provide parenting support

Behavioral: Attachment and Biobehavioral Catch up

ABC+D

EXPERIMENTAL

Attachment and Biobehavioral Catch-up plus weekly 5-10 minute videos that additional provide support for mothers' mood, stress, and coping

Behavioral: Attachment and Biobehavioral Catch up Plus Depression Treatment

Interventions

ABC is delivered by a trained parent coach. The parent coach provides information about parenting and child development. The focus is on providing support for parents of young children and improving the parent-child relationship.

Also known as: ABC
ABC

ABC+D offers the same 10-sessions of parenting support that is provided by ABC and additionally provides weekly short videos that help mothers develop skills for coping with stress and regulating mood.

Also known as: ABC+D
ABC+D

Eligibility Criteria

Age2 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Mothers 18 years of age or older with heightened depressive symptoms as determined by a score of 5 or higher on the Patient Health Questionnaire-9 (PHQ-9)
  • Biological children (of mothers described above) between 2 and 4 years old with heightened behavior problems as determined by a score of at least 3 in at least 1 domain of functioning on the Impairment Rating Scales
  • English- or Spanish-speaking

You may not qualify if:

  • Self-reported history of psychosis or active suicidality as defined by self-report of a specific suicide plan or recent attempt
  • Child diagnosis of autism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, San Francisco

San Francisco, California, 94118, United States

Location

Results Point of Contact

Title
Danielle Roubinov
Organization
University of North Carolina at Chapel Hill

Study Officials

  • Danielle Roubinov, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 25, 2021

First Posted

October 27, 2021

Study Start

March 1, 2022

Primary Completion

October 30, 2024

Study Completion

October 30, 2024

Last Updated

April 21, 2026

Results First Posted

April 21, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Data will be shared via the NIMH Data Archive (NDA)

Time Frame
Data from this clinical trial require significant processing after the completion of data collection. We will submit a clean dataset after the final data lock.
Access Criteria
Researchers will the appropriate qualifications can request the dataset via the NIMH Data Archive Platform.

Locations